Australia markets closed

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.35-0.23 (-1.07%)
At close: 04:00PM EDT
21.50 +0.15 (+0.70%)
Pre-market: 07:06AM EDT

10x Genomics, Inc.

6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
925 401 7300
https://www.10xgenomics.com

Sector(s)Healthcare
IndustryHealth Information Services
Full-time employees1,259

Key executives

NameTitlePayExercisedYear born
Dr. Serge Saxonov Ph.D.Co-Founder, CEO & Director925.05k1.98M1977
Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer & Director618.32k1.5M1975
Mr. Justin J. McAnearChief Financial Officer587.41kN/A1976
Mr. Eric S. Whitaker Esq.Chief Legal Officer615.38k3.19M1967
Mr. Michael Schnall-LevinFounding Scientist & CTON/AN/AN/A
Ms. Cassie CorneauManager of Investor Relations and Strategic FinanceN/AN/AN/A
Ms. Rebecca PortChief People OfficerN/AN/AN/A
Mr. Jens DurruthyAssociate Director of Product ManagementN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Corporate governance

10x Genomics, Inc.’s ISS governance QualityScore as of 1 June 2024 is 8. The pillar scores are Audit: 3; Board: 6; Shareholder rights: 10; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.